Markets

China-focused blank check company Longevity Acquisition files for $40 million US IPO

Longevity Acquisition, a blank check company focusing on acquiring a business in China, filed for its IPO on Wednesday.

The Shanghai, China-based company plans to raise $40 million by offering 4 million units at a price of $10. Each unit will consist of one share of common stock, one right for one tenth of one share of common stock, and one warrant to purchase one half of a share of common stock. At $10, Longevity Acquisition would command a fully diluted market value of $53 million.

Longevity Acquisition was founded in 2018 and plans to list on the Nasdaq under the symbol LOACU. Cantor Fitzgerald is the sole bookrunner on the deal. No pricing terms were disclosed.

The article China-focused blank check company Longevity Acquisition files for $40 million US IPO originally appeared on IPO investment manager Renaissance Capital's web site renaissancecapital.com.

Investment Disclosure: The information and opinions expressed herein were prepared by Renaissance Capital's research analysts and do not constitute an offer to buy or sell any security. Renaissance Capital's Renaissance IPO ETF (symbol: IPO) , Renaissance International ETF (symbol: IPOS) , or separately managed institutional accounts may have investments in securities of companies mentioned.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Other Topics

IPOs

Latest Markets Videos

    Renaissance Capital

    Renaissance Capital is the global leader in providing pre-IPO institutional research and management of IPO-focused investment products.

    Learn More